Lilly touts Omvoh’s superiority over J&J’s Stelara in Crohn’s
Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its competitor.
Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its competitor.
From October 14 to 18, with the theme Accelerate Industrial Digitalization and Intelligence, Huawei, as a Diamond Sponsor, is participating…
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
XtalPi’s AI biologics discovery platform licensed to Janssen Biotech
Lilly and insitro team up to develop AI-powered siRNA metabolic drugs
Advancing Pharmaceutical Security: The Role of SECURtracers in On-Dose Authentication
Social media algorithms are driving the GLP-1 drugs boom